Printed from https://ideas.repec.org/s/wly/hlthec15.html
Content
July 2001, Volume 10, Issue 5
- 473-477 Stochastic league tables: communicating cost‐effectiveness results to decision‐makers
by Raymond C.W. Hutubessy & Rob M.P.M. Baltussen & David B. Evans & Jan J. Barendregt & Christopher J.L. Murray
June 2001, Volume 10, Issue 4
- 277-282 Science or marketing at who? A response to Williams
by Christopher J.L. Murray & Julio Frenk & David Evans & Kei Kawabata & Alan Lopez & Orvill Adams - 283-285 Science or marketing at who? Rejoinder from Alan Williams
by Alan Williams - 287-302 The role of permanent income and family structure in the determination of child health in Canada
by Lori J. Curtis & Martin D. Dooley & Ellen L. Lipman & David H. Feeny - 303-315 A framework for cost‐effectiveness analysis from clinical trial data
by Anthony O'Hagan & John W. Stevens - 317-324 Recognizing diversity in public preferences: The use of preference sub‐groups in cost‐effectiveness analysis
by Mark Sculpher & Amiram Gafni - 325-339 Provider payment reform in China: the case of hospital reimbursement in Hainan province
by Winnie Yip & Karen Eggleston - 341-350 The effect of health on acute care supplemental insurance ownership: an empirical analysis
by Amir Shmueli - 351-356 Private and social time preferences for health and money: an empirical estimation
by Angelina Lazaro & Ramon Barberan & Encarnacion Rubio - 357-361 The impact of income inequality on individual and societal health: absolute income, relative income and statistical artefacts
by John Wildman - 363-366 Cost prediction models for the comparison of two groups
by Andrew R. Willan & Bernie J. O'Brien - 367-368 The Economic Analysis of Substance Use and Abuse: An Integration of Econometric and Behavioral Economic Research edited by F.J. Chaloupka, M. Grossman, W.K. Bickel and H. Safer. University of Chicago Press, Chicago, 1999. No. of pages 383. ISBN 0‐226‐10047‐2
by Michael T. French - 368-368 The Politics of Emerging and Resurgent Infectious Diseases edited by Jim Whitman. Macmillan Press, Basingstoke, 2000. No. of pages 223. ISBN 0‐333‐69127‐X
by Tom Jefferson
April 2001, Volume 10, Issue 3
- 187-205 Equity considerations in health care: the relevance of claims
by Xavier Cuadras‐Morató & José‐Luis Pinto‐Prades & José‐María Abellán‐Perpiñán - 207-220 Targeted health insurance in a low income country and its impact on access and equity in access: Egypt's school health insurance
by Winnie Yip & Peter Berman - 221-232 Demand for traditional medicine in Taiwan: a mixed Gaussian–Poisson model approach
by Steven T. Yen & Chao‐Hsiun Tang & Shew‐Jiuan B. Su - 233-243 On the societal value of health care: what do we know about the person trade‐off technique?
by Colin Green - 245-256 The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study
by Ruth Etzioni & Scott D. Ramsey & Kristin Berry & Martin Brown - 257-270 Alcohol abuse and economic conditions: Evidence from repeated cross‐sections of individual‐level data
by Thomas S. Dee - 271-276 Reconsideration of discharge data to measure competition in the hospital industry
by Eric Nauenberg & Yuri Andrijuk & Matthew Eisinger
March 2001, Volume 10, Issue 2
- 93-100 Science or marketing at WHO? A commentary on ‘World Health 2000’
by Alan Williams - 101-118 Alternative approaches to obtain optimal bid values in contingent valuation studies and to model protest zeros. Estimating the determinants of individuals' willingness to pay for home care services in day case surgery
by Eulàlia Dalmau‐Matarrodona - 119-134 Strategic interaction among hospitals and nursing facilities: the efficiency effects of payment systems and vertical integration
by Dwayne Banks & Elliott Parker & Jeanne Wendel - 135-145 Health insurance and health services utilization in Ireland
by Colm Harmon & Brian Nolan - 147-158 Searching for a better willingness to pay elicitation method in rural Nigeria: the binary question with follow‐up method versus the bidding game technique
by Obinna Onwujekwe - 159-174 Citizens, their agents and health care rationing: an exploratory study using qualitative methods
by Joanna Coast - 175-177 Aging and health care expenditures: A comment on Zweifel, Felder and Meiers
by Thomas E. Getzen - 179-184 The death of cost‐minimization analysis?
by Andrew H. Briggs & Bernie J. O'Brien
January 2001, Volume 10, Issue 1
- 1-7 The world‐wide growth in obesity: an economic research agenda
by Tomas Philipson - 9-25 Physicians' payment contracts, treatment decisions and diagnosis accuracy
by Izabela Jelovac - 27-37 A comparison of scoring weights for the EuroQol© derived from patients and the general public
by Daniel Polsky & Richard J. Willke & Karen Scott & Kevin A. Schulman & Henry A. Glick - 39-52 Theory versus practice: a review of ‘willingness‐to‐pay’ in health and health care
by Jan Abel Olsen & Richard D. Smith - 53-66 Parameter solicitation for planning cost effectiveness studies with dichotomous outcomes
by Martin W. McIntosh & Scott D. Ramsey & Kristin Berry & Nicole Urban - 67-78 Preventable illness and out‐of‐area travel of children in New York counties
by Jayasree Basu & Bernard Friedman - 79-82 Economic evaluation alongside n‐of‐1 trials: getting closer to the margin
by Jonathan Karnon & Nawab Qizilbash - 83-84 International health care reform: a legal, economic and political analysis. Edited by C.M. Flood. Routledge, London (2000). 315 pages. ISBN 0 415 20844 0
by Gwyn Bevan - 84-84 Clinical governance in primary care. Edited by T. van Zwanenberg and J. Harrison. Radcliffe Press Ltd., (1999). 199 pages. ISBN 1 85775 3968
by Garry Barton - 85-86 The changing hospital industry: comparing not‐for‐profit and for‐profit institutions. Edited by David M. Cutler. Chicago University Press, Chicago (2000). 384 pages, US$53.00. ISBN 0 226 13219 6
by Peter C. Smith & Andrew Street - 86-86 The global challenge of health care rationing. Edited by A. Coulter and C. Ham. Open University Press, Buckingham (2000). 267 pages. ISBN 0 335 20463 5
by Ray Robinson - 86-87 Health reform: public success, private failure. Edited by Daniel Drache and Terry Sullivan. Routledge, London (1999). 366 pages. ISBN 0 415 20236 1
by Charles Normand - 87-88 Pricing life: the controversial role of cost‐effectiveness in health care. Edited by Peter A Ubel. MIT Press, Cambridge, MA (2000). xix+208 pages, £16.95. ISBN 0 262 21016 9
by Alan Williams - 88-89 Drugs dilemmas and choices by a working party of the Royal College of Psychiatrists and the Royal College of Physicians. Gaskell, London, UK (2000). 291 pages. ISBN 1 901242 44 7.. Drugs and the law: report of the independent inquiry into the Misuse of Drugs Act 1971 by The Police Foundation, London, UK (2000). 148 pages. ISBN 0 947692 47 9
by Christine Godfrey
December 2000, Volume 9, Issue 8
- 659-667 Health economists meet the fourth tempter: drug dependency and scientific discourse
by Steve Morgan & Morris Barer & Robert Evans - 669-680 Is there a trade‐off between longevity and quality of life in Grossman's pure investment model?
by Christoph Eisenring - 681-698 Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature
by Damian Walker & Julia A. Fox‐Rushby - 699-714 Cross‐subsidization in the market for employment‐related health insurance
by Alan C. Monheit & Thomas M. Selden - 715-726 Estimating the cost of primary care training in ambulatory settings
by Andrew J. Hogan & Luisa Franzini & James R. Boex - 727-728 Complete preferences over health states: a reply to the paper by Shiell et al
by Adam Oliver - 729-731 Will our understanding of completeness ever be complete?
by Alan Shiell & Penelope Hawe & Janelle Seymour - 733-738 Age and proximity to death as predictors of GP care costs: results from a study of nursing home patients
by Ciaran O'Neill & Lindsay Groom & Anthony J. Avery & Daphne Boot & Karine Thornhill - 739-740 In pursuit of an improving National Health Service edited by Alain C. Enthoven. The Nuffield Trust, London, 1999. No. of pages: 126. ISBN 1‐902089‐37‐5
by Ted Marmor - 740-741 Cost‐value analysis in health care: making sense out of QALYs by Eric Nord. Cambridge University Press, Cambridge, 1999. No. of pages: 157. ISBN 0 521 64434 8
by Alan Williams - 741-742 The politics of Medicare (2nd Edition) by Theodore R Marmor. Aldine de Gruyter, New York, 2000. No. of pages xii+228. ISBN 0 202 30425 6
by Martin Mckee
October 2000, Volume 9, Issue 7
- 565-566 Towards multidisciplinary research into health inequalities
by Adam Oliver & Richard Cookson - 567-568 Working together for equity
by Douglas Black - 569-570 Health inequalities: bringing the hidden assumptions into the open
by Rudolf Klein - 571-574 Equity in the allocation of health care resources
by Trevor A. Sheldon & Peter C. Smith - 575-579 Rationing for health equity: is it necessary?
by George Davey Smith & Stephen Frankel & Shah Ebrahim - 581-583 The need for an interdisciplinary perspective on the social determinants of health
by Richard G. Wilkinson - 585-586 Equity in health: a challenge for researchers and policy makers
by Alan Williams - 587-598 Interpreting the rational addiction model
by Brian S. Ferguson - 599-609 A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty
by Maiwenn J. Al & Ben A. Van Hout - 611-621 The social value of health programmes: is age a relevant factor?
by Eva Rodríguez & José Luis Pinto - 623-630 Definition, interpretation and calculation of cost‐effectiveness acceptability curves
by Mickael Löthgren & Niklas Zethraeus - 631-641 Institutional considerations in priority setting: transactions cost perspective on PBMA
by Stephen Jan - 643-657 The price of placements in residential and nursing home care: the effects of contracts and competition
by Julien Forder & Ann Netten
September 2000, Volume 9, Issue 6
- 463-464 Guest editors' introduction
by Andrew Jones & Owen O'Donnell - 465-474 Identifying demand for health resources using waiting times information
by Richard Blundell & Frank Windmeijer - 475-489 Estimates of use and costs of behavioural health care: a comparison of standard and finite mixture models
by Partha Deb & Ann M. Holmes - 491-511 The effect of smoking on health using a sequential self‐selection model
by Kajal Lahiri & Jae G. Song - 513-531 The use of long‐term care services by the Dutch elderly
by France Portrait & Maarten Lindeboom & Dorly Deeg - 533-545 Health services utilization of elderly Swiss: evidence from panel data
by Martin Schellhorn & Andreas E. Stuck & Christoph E. Minder & John C. Beck - 547-559 Regional differences in health care delivery: implications for a national resource allocation formula
by Matthew Sutton & Peter Lock - 561-564 A note on risk adjustment and fair compensation
by Amir Shmueli
July 2000, Volume 9, Issue 5
- 369-372 Burden of disease and priority setting
by Gavin Mooney & Virginia Wiseman - 373-383 Using health production functions to evaluate treatment effectiveness: an application to a community mental health service
by Andrew Healey & Massimo Mirandola & Francesco Amaddeo & Paola Bonizzato & Michele Tansella - 385-395 Preference measurement using conjoint methods: an empirical investigation of reliability
by Stirling Bryan & Lisa Gold & Rob Sheldon & Martin Buxton - 397-409 Cost function estimation: the choice of a model to apply to dementia
by Christian Kronborg Andersen & Kjeld Andersen & Per Kragh‐Sørensen - 411-421 The cost‐effectiveness of evidence‐based guidelines and practice for screening and prevention of tuberculosis
by C.R. Macintyre & A.J. Plant & D. Hendrie - 423-434 Determinants of ambulatory treatment mode for mental illness
by Marc P. Freiman & Samuel H. Zuvekas - 435-446 A multilevel modelling approach to analysis of patient costs under managed care
by Kathleen Carey - 447-461 Competition and dental services
by Jostein Grytten & Rune Sørensen
June 2000, Volume 9, Issue 4
- 277-294 Hospital response to DRG refinements: the impact of multiple reimbursement incentives on inpatient length of stay
by Boyd H. Gilman - 295-317 Willingness to pay for improved respiratory and cardiovascular health: a multiple‐format, stated‐preference approach
by F. Reed Johnson & Melissa Ruby Banzhaf & William H. Desvousges - 319-326 Mother's willingness to pay for her own and her child's health: a contingent valuation study in Taiwan
by Jin‐Tan Liu & James K. Hammitt & Jung‐Der Wang & Jin‐Long Liu - 327-335 Fieller's method and net health benefits
by Daniel F. Heitjan - 337-351 Evidence‐based medicine and health economics: a case study of end stage renal disease
by Luke Vale & Cam Donaldson & Conal Daly & Marion Campbell & June Cody & Adrian Grant & Izhar Khan & Paul Lawrence & Shiela Wallace & Alison Macleod - 353-365 Discrete time representation of the formula for calculating DALYs
by Elamin H. Elbasha
April 2000, Volume 9, Issue 3
- 183-190 Health economics: an evolving paradigm
by Alan Maynard & Panos Kanavos - 191-198 Centre‐specific or average unit costs in multi‐centre studies? Some theory and simulation
by M. Raikou & A. Briggs & A. Gray & A. McGuire - 199-210 The effect of capitation on GPs' referral decisions
by Tor Iversen & Hilde Lurås - 211-226 Can cost shifting continue in a price competitive environment?
by Jack Zwanziger & Glenn A. Melnick & Anil Bamezai - 227-234 Power and sample assessments for tests of hypotheses on cost‐effectiveness ratios
by Joseph C. Gardiner & Marianne Huebner & James Jetton & Cathy J. Bradley - 235-251 Development of WHO guidelines on generalized cost‐effectiveness analysis
by Christopher J.L. Murray & David B. Evans & Arnab Acharya & Rob M.P.M. Baltussen - 253-255 Uncertainty aversion: a reply to the paper by Andersson and Lyttkens
by Adam Oliver - 257-259 Uncertainty aversion—a reply to Oliver
by Fredrik Andersson & Carl Hampus Lyttkens - 261-263 Uncertainty aversion: a discussion of critical issues in health economics
by Peter P. Wakker - 267-270 The veil of experience: do consumers prefer what they know best?
by G. Salkeld & M. Ryan & L. Short
March 2000, Volume 9, Issue 2
- 89-93 A nice challenge for health economics
by John Hutton & Alan Maynard - 95-107 Enhancing performance in health care: a theoretical perspective on agency and the role of information
by Maria Goddard & Russell Mannion & Peter Smith - 109-126 Sensitivity and perspective in the valuation of health status: whose values count?
by G. Ardine De Wit & Jan J.V. Busschbach & Frank Th. De Charro - 127-136 Societal value, the person trade‐off, and the dilemma of whose values to measure for cost‐effectiveness analysis
by Peter A. Ubel & Jeff Richardson & Paul Menzel - 137-148 Public preferences for the allocation of donor liver grafts for transplantation
by Julie Ratcliffe - 149-158 Establishing health state valuations for disease specific states: an example from heart disease
by J. Kirsch & A. McGuire - 159-170 The impact of clean indoor‐air laws and cigarette smuggling on demand for cigarettes: an empirical model
by Ayda A. Yurekli & Ping Zhang - 171-175 Negative and zero time preference for health
by Marjon M. Van Der Pol & John A. Cairns - 177-180 Are QALYs an appropriate measure for valuing morbidity in acute diseases?
by Mohan V. Bala & Gary A. Zarkin
January 2000, Volume 9, Issue 1
- 1-7 Managed care in the United States: a dilemma for evidence‐based policy?
by Ray Robinson - 9-18 The relationship between marijuana initiation and dropping out of high school
by Jeremy W. Bray & Gary A. Zarkin & Chris Ringwalt & Junfeng Qi - 19-35 Policy analysis of the use of hepatitis B, Haemophilus influenzae type b‐, Streptococcus pneumoniae‐conjugate and rotavirus vaccines in national immunization schedules
by Mark A. Miller & Laura McCann - 37-46 Measuring productivity loss days in asthma patients
by Wendy J. Ungar & Peter C. Coyte & The Pharmacy Medication Monitoring Program Advisory Board - 47-55 Are preferences over health states complete?
by Alan Shiell & Janelle Seymour & Penelope Hawe & Sue Cameron - 57-68 QALYs and ageism: philosophical theories and age weighting
by Aki Tsuchiya - 69-82 Progress and directions in refining the Global Burden of Disease approach: a response to Williams
by Christopher J.L. Murray & Alan D. Lopez - 83-86 Comments on the response by Murray and Lopez
by Alan Williams
December 1999, Volume 8, Issue 8
- 653-660 Carrots and sticks—the fall and fall of private health insurance in Australia
by Jane Hall & Richard De Abreu Lourenco & Rosalie Viney - 661-683 Parental use of alcohol and children's behavioural health: a household production analysis
by Alison Snow Jones & Deborah J. Miller & David S. Salkever - 685-699 The role of a pre‐scored multi‐attribute health classification measure in validating condition‐specific health state descriptions
by Karen Gerard & Katharine Johnston & Jackie Brown - 701-707 Health state after treatment: a reason for discrimination?
by Jose‐Maria Abellan‐Perpiñan & Jose‐Luis Pinto‐Prades - 709-720 Long‐term contracts in the NHS: a solution in search of a problem?
by Diane Dawson & Maria Goddard - 721-733 Demand inducement as cheap talk
by Paul Calcott - 735-736 The ethical QALY. Ethical issues in healthcare resource allocations by Andrew Edgar, Sam Salek, Darren Shickle and David Cohen. Euromed Communications, Haslemere, UK, 1998. No. of pages: 168. ISBN 1‐8‐99015‐213. The allocation of health care resources. An ethical evaluation of the ‘QALY’ approach by John McKie, Jeff Richardson, Peter Singer and Helga Kuhse. Medico Legal Series, Ashgate, Dartmouth, 1998. No. of pages: 151. ISBN 1‐85521‐9530
by Alan Williams
November 1999, Volume 8, Issue 7
- 563-578 Community rating and choice between traditional health insurance and managed care
by Mathias Kifmann - 579-598 Duplicate coverage and demand for health care. The case of Catalonia
by Ángel Marcos Vera‐Hernández - 599-612 The impact of generic goods in the pharmaceutical industry
by Jorge Mestre Ferrándiz - 613-625 Health care and economic well‐being: estimating equivalence scales for public health care utilization
by Jan Klavus - 627-639 Health care spending as determinants of health outcomes
by Pierre‐Yves Crémieux & Pierre Ouellette & Caroline Pilon - 641-651 The impact of teaching status on average costs in Spanish hospitals
by Guillem López‐Casasnovas & Marc Saez
September 1999, Volume 8, Issue 6
- 485-496 Ageing of population and health care expenditure: a red herring?
by Peter Zweifel & Stefan Felder & Markus Meiers - 497-508 Competition and supplier‐induced demand in a health care system with fixed fees
by Rune J. Sørensen & Jostein Grytten - 509-520 On measuring the hospital cost/quality trade‐off
by Kathleen Carey & James F. Burgess - 521-530 A comparison of hospital scale effects in short‐run and long‐run cost functions
by Vassilis H. Aletras - 531-540 Costs of screening for colorectal cancer: An Australian programme
by Jeff Gow - 541-545 A comparison of patient and social tariff values derived from the time trade‐off method
by Niklas Zethraeus & Magnus Johannesson - 547-552 Inferring capitation rates from aggregate health plans’ costs
by Amir Shmueli - 553-553 The Health Care Marketplace by Warren Greenberg. Springer‐Verlag, New York, 1998. No. of pages 170. ISBN 0‐387‐98457‐7
by Ciaran O'Neill - 554-554 Krankenhaus‐Report ’97: Aktuelle Beitrage, Trends und Statistiken edited by M. Arnold and D. Paffrath. Fischer, Stuttgart, 1997. ISBN 3‐437‐21248‐6
by Florian Hollenbach - 555-555 Arznei‐Verordungs‐Report ’97: Aktuelle Daten, Kosten, Trends und Kommentare edited by Ulrich Schwabe. Fischer, Stuttgart, 1997. ISBN 3‐437‐21091‐2
by Florian Hollenbach - 556-556 Community Care in England and France: Reforms and the Improvement of Equity and Efficiency by Bleddyn Davies, Jose Fernandez and Robin Saunders. Ashgate Arena, Aldershot 1998. ISBN 1‐840‐14584‐6
by Ken Wright - 557-557 Cost–Outcome Methods for Mental Health by William A. Hargreaves, Martha Shumway, Tei‐Wei Hu and Brian Cuffel, Academic Press, New York, 1998. ISBN 0‐123‐25155‐9
by Martin Knapp - 558-559 Screening. British Medical Bulletin, Vol. 54, No. 4 edited by C. Peckham and C. Dezateux. Royal Society of Medicine Press, 1998. ISBN 1‐853‐15345‐1
by Miranda Mugford - 560-560 Learning from the NHS internal market. A review of the evidence edited by Julian Le Grand, Nicholas May and Jo‐Ann Mulligan. King's Fund Publishing, 1998. No. of pages: 145. ISBN 1‐857‐17215‐9. £17.95
by Charles Normand - 561-561 Errata
by Andrew Willan - 562-562 Errata
by Erik Nord
August 1999, Volume 8, Issue 5
- 367-368 Guest editors’ introduction
by Andrew Jones & Owen O'Donnell - 369-378 Preferences for equity in health behind a veil of ignorance
by Fredrik Andersson & Carl Hampus Lyttkens - 379-389 Gender, heroin consumption and economic behaviour
by Anne Line Bretteville‐Jensen - 391-402 A model for the Dutch pharmaceutical market
by Erik Canton & Ed Westerhout - 403-414 HMO selection and Medicare costs: Bayesian MCMC estimation of a robust panel data tobit model with survival
by Barton H. Hamilton - 415-428 Women's participation in rural credit programmes in Bangladesh and their demand for formal health care: is there a positive impact?1
by Priya Nanda - 429-440 Non‐ and semi‐parametric estimation of age and time heterogeneity in repeated cross‐sections: an application to self‐reported morbidity and general practitioner utilization1
by David Parkin & Nigel Rice & Matthew Sutton - 441-458 Health and mortality of the elderly: the grade of membership method, classification and determination
by France Portrait & Maarten Lindeboom & Dorly Deeg - 459-472 Sensitivity of elasticity estimates for OECD health care spending: analysis of a dynamic heterogeneous data field
by Jennifer Roberts
June 1999, Volume 8, Issue 4
- 281-282 Inequalities in health: an introductory editorial
by Alan Maynard - 283-288 Income inequality in the UK
by A.B. Atkinson - 289-296 ‘Our healthier nation’?
by Paul Contoyannis & Martin Forster - 297-299 Commentary on the Acheson Report
by Alan Williams - 301-308 The 39 steps: the mystery of health inequalities in the UK
by Stephen Birch - 309-321 The effects of economic reform on health insurance and the financial burden for urban workers in China
by Teh‐Wei Hu & Michael Ong & Zi‐Hua Lin & Elizabeth Li - 323-333 Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis
by Joanne Lord & Maxwell A. Asante - 335-343 Addressing the inequity of capitation by variable soft contracts
by Amir Shmueli & Jacob Glazer - 345-353 The appropriate uses of qualitative methods in health economics
by Joanna Coast - 355-362 Do you sincerely want to be rich?
by Uwe Reinhardt - 363-364 Health economics of dementia by A. Wimo, B. Jönsson, G. Karlsson and B. Winblad. John Wiley & Sons, Chichester, 1998. No. of pages: 576. ISBN 0‐471‐98376‐4
by Alan Stewart - 364-364 Health, health care and health economics: perspectives on distribution edited by M.L. Barer, T.E. Getzen and G.L. Stoddart. Wiley, Chichester, 1998. No. of pages: 551. ISBN 0‐471‐97879‐5
by Owen O'Donnell - 365-365 Pharmaceutical price regulation: national policies versus global interests by Patricia M. Danzon. The American Enterprise Institute Press, Washington, DC, 1997. No. of pages: 107. ISBN 0‐8447‐3982‐0
by Panos Kanavos
May 1999, Volume 8, Issue 3
- 187-189 Redefining the analytical approach to pharmacoeconomics
by Bryan R. Luce & Karl Claxton - 191-201 Bayesian estimation of cost‐effectiveness ratios from clinical trials
by Daniel F. Heitjan & Alan J. Moskowitz & William Whang - 203-211 Sample size and power issues in estimating incremental cost‐effectiveness ratios from clinical trials data
by Andrew R. Willan & Bernie J. O'Brien - 213-219 At what price significance? The effect of price estimates on statistical inference in economic evaluation
by Brian E. Rittenhouse & Brian Dulisse & Aaron A. Stinnett - 221-232 Will the real elasticity of substitution ‘in Norwegian dentistry’ please stand up?
by Albert A. Okunade - 233-243 Price competition and hospital cost growth in the United States (1989–1994)
by Anil Bamezai & Jack Zwanziger & Glenn A. Melnick & Joyce M. Mann - 245-255 Annuitizing the human capital investment costs of health service professionals
by Ann Netten & Jane Knight - 257-261 A Bayesian approach to stochastic cost‐effectiveness analysis
by Andrew H. Briggs - 263-268 A Bayesian approach to sensitivity analysis
by James C. Felli & Gordon B. Hazen - 269-274 Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals
by Karl Claxton - 275-276 Markets and health care: a comparative analysis edited by W. Ranadae. Longman, Harlow, 1998. No. of pages: 223. ISBN 0 582 28985 8
by Gwyn Bevan - 276-276 Making sense of the new NHS White Paper by Mark Baker. Radcliffe Medical Press: Abingdon, Oxon, 1998. No. of pages: 143. ISBN 1‐85775‐239‐2
by Paul Plant - 279-279 IHEA 2nd World Conference: Private and Public Choices in Health and Health Care, 6–9 June 1999, World Trade Center, Rotterdam, Netherlands
by Frans Rutten - 280-280 Eighth European Workshop on Econometrics and Health Economics; 9–11 September 1998; University of Catania, Italy
by Andrew Jones
March 1999, Volume 8, Issue 2
- 93-101 Medical negligence and the NHS: an economic analysis
by Adrian Towse & Patricia Danzon - 103-116 Modelling the EuroQol data: a comparison of discrete choice conjoint and conditional preference modelling
by Zafar Hakim & Dev S. Pathak - 117-126 The weighting exercise for the Swedish version of the EuroQol
by Stefan Björk & Anna Norinder - 127-136 Policy‐induced changes in Maori mortality patterns in the New Zealand economic reform period
by Malcolm C. Brown - 137-150 Varying health care provider objectives and cost‐shifting: the case of retail pharmacy in the US
by John M. Brooks & Bernard Sorofman & William Doucette - 151-164 Internal markets and health care efficiency: a multiple‐output stochastic frontier analysis
by U.‐G. Gerdtham & M. Löthgren & M. Tambour & C. Rehnberg - 165-169 Health knowledge and smoking among South African women
by Andrew M. Jones & Joses M. Kirigia - 171-174 Ratio‐based and net benefit‐based approaches to health care resource allocation: proofs of optimality and equivalence
by Eugene M. Laska & Morris Meisner & Carole Siegel & Aaron A. Stinnett - 175-176 Health economics has lost its way—or why David Kernick is (partly) right
by Ruth Mcdonald - 177-177 US and UK health economics: a reply to Joe Newhouse's paper
by Paul Dolan - 179-180 Response to Paul Dolan
by Joseph P. Newhouse - 181-182 The economics of health reconsidered by Thomas Rice. Health Administration Press, Chicago, 1998. No. of pages: 195. ISBN 1‐5679‐073‐5
by Gavin Mooney - 182-183 Being reasonable about the economics of health. Selected assays by Alan Williams edited by A.J. Culyer and A.K. Maynard, Edward Elgar Publishing, Cheltenham. No. of pages: 371. ISBN 1 85898 648 6
by Jack Dowie - 183-185 Office of Health Economics publications from 1997 and 1998. Office of Health Economics, 12 Whitehall, London SW1A 2DY, UK
by Cam Donaldson - 185-185 Dictionary of evidence‐based medicine by Alain Li Wan Po. Radcliffe Medical Press, Oxford, 1998. No. of pages: 165. ISBN 1 85775 305 4
by Nick Freemantle
February 1999, Volume 8, Issue 1
- 1-8 Calculating the global burden of disease: time for a strategic reappraisal?
by Alan Williams - 9-24 It'll only hurt a second? Microeconomic determinants of who gets flu shots
by John Mullahy - 25-39 Incorporating societal concerns for fairness in numerical valuations of health programmes
by Erik Nord & Jose Luis Pinto & Jeff Richardson & Paul Menzel & Peter Ubel